香京julia种子在线播放

Giardia lamblia is an extracellular gastrointestinal parasite with a wide global distribution and still remains a common cause of food and waterborne-associated diarrhoeal disease (Figure 1A; Halliez and Buret, 2013). Giardia trophozoites attach to the epithelial lining of the small intestine and therefore they remain in intimate contact with the resident commensal microbiota of the host (Adam, 2001). Giardia infection in mice leads to localized shifts in the commensal microbial communities of the host small intestine. However, few studies have characterized the dynamics of Giardia-microbiota interactions in greater detail. During the early stages of infection, increased numbers of adherent and mucus-associated bacteria, as well as epithelial cell damage-related translocation of commensal bacteria from the intestine to the spleen and liver have been demonstrated (Chen et al., 2013; Halliez et al., 2016).

Acute infection with G. lamblia in mice has been shown to cause a significant expansion of β- and γ-Proteobacteria in the small intestine, cecum and colon, whereas the relative abundance of Clostridia and the diversity of Melainabacteria is decreased (Figure 2A; Barash and Maloney, 2017). Importantly, additional perturbations of the microbiota following antibiotic administration did not prevent the observed shifts in gut microbiota during murine giardiasis (Barash and Maloney, 2017). Investigations of the impact of diet on Giardia-induced changes in microbial composition have further revealed that while a low protein diet resulted in an increased Firmicutes/Bacteroidetes ratio, Giardia infection further enhanced the compositional shift in favor of Firmicutes, predominantly of Clostridiales, Turicibacter, and Enterococcus (Bartelt et al., 2017). In addition, Giardia infection increases excretion of bile acid derivatives, phosphatidylcholine, and taurine metabolites, as well as the availability of byproducts of glucose metabolism, indicating Giardia-induced alterations of host metabolism as a potential contributor to commensal microbiota alterations observed during infection (Barash and Maloney, 2017).

In contrast, the intracellular apicomplexan parasite Toxoplasma gondii initially infects the small intestine, where it induces significant immunopathological damage before quick systemic dissemination in the host (Figure 1A; Wilhelm and Yarovinsky, 2014). Despite the direct damage to host epithelial cells inflicted during intracellular parasite development, compositional changes in host intestinal microbiota have been established as a key factor driving intestinal immunopathology of toxoplasmosis in wild-type and humanized mice (Heimesaat et al., 2006; Bereswill et al., 2014; Von Klitzing et al., 2017). T. gondii infection causes a notable expansion of Enterobacteriaceae, Bacteroides, and Enterococcus (Heimesaat et al., 2006, 2014) and a decrease in Lactobacillus, Bifidobacterium, Clostridia, and Bacteroidetes species (Figure 2B; Heimesaat et al., 2006; Molloy et al., 2013). The expansion of predominantly Gram-negative commensal bacteria elevates proinflammatory cytokine production in the gut and the immunopathology of toxoplasmosis (Heimesaat et al., 2006). Similar to Giardia, T. gondii infection induces strong compositional changes in the gut microbiota, that contribute to the intestinal immunopathology of toxoplasmosis (Figure 2B).

Infection with the murine small intestinal nematode H. polygyrus leads to profound changes in the host commensal microbiota along the entire gastrointestinal tract (Walk et al., 2010; Rausch et al., 2013; Reynolds et al., 2014). In particular, Lachnospiraceae, Ruminoccoccaceae, γ-Proteobacteria/Enterobacteria, and Bacteroides dominate the cecum, while a greater abundance of Porphyromonadaceae, Lactobacillaceae, and Clostridiaceae was detected in the ileum (Figure 2C; Walk et al., 2010; Rausch et al., 2013). Importantly, Reynolds et al. (2014) have correlated host susceptibility to infection with a significant increase in Lactobacilli. Overall, infections with H. polygyrus appear to change the balance between Bacteroidetes and Firmicutes in favor of the latter (Figure 2C).

The murine whipworm T. muris, on the other hand, develops in the large intestine, where the adult parasites protrude through the epithelium into the lumen (Holm et al., 2015). Trichuris adults, therefore, reside in close proximity the resident commensal microbiota of the host. Several studies have previously demonstrated that murine infection with T. muris results in shifts in the microbiota composition in the caecum and colon (Figure 2D; Holm et al., 2015; Houlden et al., 2015). During the early stages of infection, an increase in the abundance of Bifidobacteria, Lactobacilli, Alistipes, Parabacteroides, and Odirobacter has been observed. Later chronic stages increased the abundance of Oscillibacter, Butyricicoccus, Parasutterella, Sphyngomonas, and Halomonas, paralleled by a decrease in Roseburia, Allobaculum, and Barnesiella genera (Figure 2D; Holm et al., 2015). A significant reduction of Bacteroides correlated with a shift in the metabolite composition of the gut, affecting the biosynthesis of fatty acids, amino acids and phospholipids (Houlden et al., 2015). Interestingly, type 1 fimbriae adhesins, structural components of the commensal bacterium E. coli, were demonstrated to induce T. muris egg hatching in vitro (Hayes et al., 2010). Consistently, depletion of the host microbiota inhibits the establishment of infection in vivo (Hayes et al., 2010). Interestingly, changes in host microbiota caused by primary T. muris infection have been shown to inhibit egg hatching of secondary infections with T. muris, suggesting that some microbial products facilitate establishment of T. muris during primary, but not secondary infections (White et al., 2018). Overall, intestinal nematodes appear to change the microbiota composition of their hosts and alterations of the balance in abundances of Firmicutes and Bacteroides have been highlighted as a shared feature in these infection models.

In contrast to mammalian intestinal parasites residing primarily in the intestinal lumen and allow for continuous interaction between the parasites and the host microbiota, Plasmodium swiftly transits through the mosquito gut without establishing long-term residence in the lumen. The time that the parasite remains in contact with the luminal bacteria following a blood intake is limited to 24–30 h, by which time the majority of the parasites have already traversed the gut epithelium to escape the dangerous environment (Meis et al., 1989). Therefore, the impact of Plasmodium on the gut microbiota at this stage would be limited. Sporogonic parasite development at the basal side of the gut takes approximately 2 weeks. During this time, potential indirect parasite interactions with midgut bacteria could take place. Tchioffo et al. (2016) observed significant differences between mosquito microbial communities in the gut, ovaries and salivary glands at 1 and 8 days after P. falciparum infection. However, it is unclear whether immune or metabolic factors mediate these changes. Mosquito immune responses target predominantly the midgut-traversing ookinetes, whereas exposure of early oocysts to immune attacks is limited, questioning the role of anti-parasitic immunity in the observed microbiota changes (Garver et al., 2012). As Plasmodium oocysts scavenge mosquito lipids, and possibly other nutrients essential for their proliferation and virulence (Costa et al., 2017), the parasite may directly impact mosquito metabolism. However, it remains to be investigated whether Plasmodium competes with bacteria during its gut development for the same resources, or directly impacts mosquito metabolism.

Protective immunity to Giardia predominantly relies on the secretion of intestinal IgA and the induction of pro-inflammatory Th17 responses, supporting neutrophil recruitment and secretion of antimicrobial peptides (Dann et al., 2015; Saghaug et al., 2015). However, our current understanding of the potential immunomodulatory roles of the commensal microbiota in the induction and maintenance of host immunity against Giardia remains very limited. Although microbiota-independent CD4⁺ T-cell responses appear crucial for host protection, CD8⁺ T cell activation has been shown to be ablated in the gut of infected animals treated with antibiotics, suggesting a potential involvement of the intestinal microbiota in the activation of CD8⁺ T cell responses during giardiasis (Keselman et al., 2016). The mechanisms of CD8⁺ T-cell activation and their potential contribution to immune control during infection with Giardia, however, remain to be established (Keselman et al., 2016). Susceptibility to G. lamblia infection has previously been shown to vary in mice with an identical genetic background, but originating from independent commercial suppliers, further implicating host microbiota composition in shaping the course of Giardia infection (Singer and Nash, 2000). The microbiota of resistant mouse strains was later shown to contain Segmented Filamentous Bacteria (SFB), members of the family Clostridiales, while susceptible mice lacked this group (Ivanov et al., 2008). Importantly, SFB play a central role in the induction of intestinal Th17 responses (Ivanov et al., 2009), suggesting that microbiota-driven support for Th17 responses potentially facilitates immune control of Giardia infections. However, a direct link between the immunostimulatory properties of SFB and susceptibility to infection with Giardia remains to be established (Figure 3A).

T. gondii infection in mice, on the other hand, leads to potent Th1 immune responses and importantly, resident intestinal bacteria are known to play an important role in localized intestinal Th1 response polarization by providing molecular adjuvant signals in a TLR/MyD88-dependent manner, thus triggering IL-12 and IFN-γ production (Figure 3B; Benson et al., 2009). Studies have demonstrated the formation of distinct structured accumulations of host cells along the ileum of T. gondii-infected mice, named “intracellular casts,” which contained elevated levels of γ-Proteobacteria and were enriched for highly activated neutrophils and ROS-producing inflammatory monocytes (Grainger et al., 2013; Molloy et al., 2013). Further analysis revealed that the presence and expansion of γ-Proteobacteria positively influenced neutrophil infiltration into the lumen and, hence, played a role in the induction of intraluminal casts formation, suggesting that commensal bacteria potentially contribute to bacterial overgrowth and support the control of overt pathology during acute murine toxoplasmosis (Molloy et al., 2013). Additionally, inflammatory monocytes from small intestinal lamina propria were shown to adopt a mixed proinflammatory/regulatory phenotype during acute infection with T. gondii. The parallel secretion of IL-10, TNF-α, and PGE2 by these monocytes was demonstrated to depend on a range of commensal bacteria-derived ligands and has been correlated with potential PGE2-dependent suppression of commensal-driven neutrophil activation (Grainger et al., 2013). Moreover, toxoplasmosis is associated with the differentiation of CD4⁺ T cells specific for commensal microbes marked by a Th1 phenotype in a manner similar to parasite-specific Th1 cells (Figure 3B; Hand et al., 2012).

Efficient immune control of intestinal nematodes largely depends on the development of protective type 2 immune responses driven by CD4⁺ Th2 cells in concert with type 2 innate lymphoid cells. Both cell types produce the Th2 cytokines IL-4, −5, and −13 leading to concerted immune effector mechanisms. These mechanisms fortify intestinal barriers via enhanced mucus production, increased epithelial cell turnover, intestinal fluid influx and hypercontraction of smooth muscle cells (Sorobetea et al., 2018). Nematode infections additionally support the activation and expansion of regulatory T cells (Tregs) (Maizels et al., 2012), a phenomenon linked to the anti-inflammatory effect of nematode infections in several models of autoimmunity (McSorley and Maizels, 2012).

Whether the microbiota affects the development of immune effector mechanisms during nematode infections has only recently received attention. One study has reported that low dose antibiotic treatment during H. polygyrus infection increased the abundance of members of the Lactobacillaceae and Enterobacteriaceae bacterial families (Reynolds et al., 2014). Lactobacilli abundance correlated positively with worm burdens, and, importantly, with higher numbers of Foxp3⁺ Tregs in gut-associated lymphoid tissue, suggesting Lactobacilli-mediated induction of Treg responses (Figure 3C). However, increased Lactobacilli abundance was observed only in C57BL/6 mice permissive for long-lasting infections with high worm burdens, while more resistant BALB/c mice did not display this phenotype. Interestingly, administration of Lactobacilli to more resistant mice increased their susceptibility to infection (Reynolds et al., 2014). In addition, H. polygyrus-dependent changes in intestinal microbiota composition have been correlated to the suppression of allergic airway inflammation. High concentrations of short-chain fatty acids (SCFA) resulted from the increased abundance of Clostridiales bacteria in H. polygyrus infected mice (Figure 3C; Zaiss et al., 2015). The SCFA increase supports mucosal Treg responses associated with the reduced susceptibility of mice to allergic airway inflammation (Zaiss et al., 2015). Furthermore, Ohnmacht et al. (2015) found that the microbiota is needed for the induction of highly activated RORγT⁺ Foxp3⁺ Tregs, which could be induced via the introduction of a cocktail of Clostridia species in germfree mice, most likely via the provision of the SCFA butyrate (Figure 3C). Importantly, the conditional removal of the RORγT⁺ Treg subset rendered H. polygyrus-infected mice more resistant to infection due to the development of a more robust Th2 response. Together, these observations suggest that the microbiota can indirectly control intestinal Th2 responses via the induction and maintenance of suppressive Treg subsets in the context of intestinal nematode infections (Figure 3C; Ohnmacht et al., 2015).

T. muris infection, on the other hand, leads to a notable decrease in Bacteroides producing SCFA, and a concomitant decrease in Foxp3⁺ Tregs in the lamina propria during chronic infection (Houlden et al., 2015). Moreover, Tregs in T. muris infection appeared less prone to release the anti-inflammatory cytokine IL-10. Therefore, chronically infected mice were more susceptible to intestinal inflammation and displayed poor worm expulsion due to the development of Th1 responses counteracting Th2 immunity (Figure 3D; Holm et al., 2015). Thus, in nematode infection, the commensal microbiota and, importantly, specific bacterial groups, appear essential for both the induction and suppression of host immune responses. Contextually, this can contribute to resistance or susceptibility to infection, depending on the bacterial community and the invading parasite species.

Multiple reports in the past have highlighted the ability of bacteria to inhibit the establishment of Plasmodium infection in the mosquito host (Gonzalez-Ceron et al., 2003; Dong et al., 2009; Cirimotich et al., 2011; Tchioffo et al., 2013; Bahia et al., 2014). Consistently, some antibiotic treatments promote parasite development (Beier et al., 1994; Dong et al., 2009; Gendrin et al., 2015, 2016). Plasmodicidal properties have been reported for diverse microbes and must rely on some general rather than species-specific mechanisms (Lowenberger et al., 1999; Gonzalez-Ceron et al., 2003; Dong et al., 2009; Cirimotich et al., 2011; Tchioffo et al., 2013).

Female mosquitoes alternate between sugar and blood feeding. Such diverse diets expose the gut to strong physiological and oxidative challenges (reviewed in Sterkel et al., 2017). Uptake of proteins and lipids from iron and heme-rich blood induces massive metabolic and transcriptional changes in the midgut (Figure 4). Nutrient abundance sets off bacterial proliferation which, in turn, induces expression of immune genes (Dong et al., 2009). Blood intake elevates hydrogen-peroxide levels in the mosquito hemolymph and activates reactive oxygen species (ROS) detoxification responses (Kumar et al., 2003; Molina-Cruz et al., 2008; de Almeida Oliveira et al., 2012). However, how blood-feeding affects ROS levels in the midgut, and the underlying mechanisms remain unknown (Figure 4B). What is clear is that ROS inhibition after blood feeding causes lethal systemic bacterial infections, suggesting a crucial link between oxidative stress and immune activation (Molina-Cruz et al., 2008).

The peritrophic matrix (PM) provides the first line of defense against blood meal-induced oxidative stress and bacterial infections (Figures 1, 4B). The cardia cells of mosquito larvae continuously secrete sleve-shaped PM (type II), whereas adult epithelial midgut cells synthesize type I PM only after blood feeding (Wigglesworth, 1930; Waterhouse, 1953). Feeding on complex organic matter continuously exposes larvae to bacteria. In contrast, blood feeding induces massive bacterial proliferation in the gut and renders adult females particularly vulnerable to microbial infections (Dong et al., 2009; Linenberg et al., 2016). Such differences in mosquito exposure to microbes at these developmental stages likely contribute to constant PM secretion in larvae vs. inducible PM secretion in adults. Interestingly, PM synthesis in adults requires midgut microbiota. Bacterial proliferation after blood feeding upregulates expression of hundreds of genes, including the genes encoding PM proteins such as glucosamine-fructose-6-phosphate aminotransferase (GFAT) and chitin synthase enzyme 1 (CHS1; Rodgers et al., 2017). Conversely, antibiotic treatment before blood feeding compromises the integrity of PM by inhibiting expression of GFAT and CHS1, but also the genes encoding peritrophic proteins 1 and 14, whereas it upregulates expression of the PM-degradation chitinase genes A and B (Rodgers et al., 2017; Song et al., 2018). The PM of mosquitoes, therefore, serves as an inducible protective mechanical barrier against bacteria.

The immune-deficiency (IMD) pathway, initially identified in Drosophila, is the major immune pathway that control bacterial infections by coordinated expression of antimicrobial peptide (AMPs) genes (Buchon et al., 2009; Broderick et al., 2014). In Anopheles, the pathway is activated by the recognition of DAP-type and lysine-type peptidoglycans by the peptidoglycan recognition protein LC (PGRP-LC; Meister et al., 2009). Although relatively understudied in the mosquito gut, several lines of evidence suggest that IMD is functional in this tissue. A. gambiae mosquitoes with intact microbiota display higher basal expression levels of immune genes compared to antibiotic-treated controls (Figure 4A; Dong et al., 2009). These genes encode a range of AMPs, signal-transducing serine proteases, IMD pathway components and immune genes such as fibrinogen-related and thioester-containing proteins among others (Dong et al., 2009). Importantly, silencing of a transcriptional activator of the NF-kB family, REL2 and of PGRP-LC receptor, promotes the proliferation of gut microbiota and increases mosquito susceptibility to Plasmodium infection (Dong et al., 2009; Meister et al., 2009). The proliferation of bacteria is believed to activate the IMD pathway via the PGRP-LC receptor. Since bacterial proliferation 24 h after blood feeding coincides with ookinete transversal of the midgut epithelium, it may also lead to the IMD-mediated killing of Plasmodium parasites (Figure 4B; Dong et al., 2009; Meister et al., 2009; Linenberg et al., 2016). Indeed, clearance of the mosquito microbiota by antibiotics before infection increases mosquito susceptibility to Plasmodium, whereas bacteria inoculation by feeding decreases it in a PGRP-LC-dependent manner (Meister et al., 2009).

Wolbachia, intracellular maternally transmitted bacteria, confer protection to their arthropod hosts against a range of pathogens (Hedges et al., 2008; Teixeira et al., 2008; Kambris et al., 2009; Moreira et al., 2009; Hughes et al., 2011). Wolbachia has been identified in natural Anopheles populations in Burkina Faso and Mali (Baldini et al., 2014; Gomes et al., 2017). Importantly, Wolbachia infections (experimental transovarian of the Asian malaria vector A. stephensi, natural infections of A. coluzzii and somatic infections in A. gambiae) significantly decrease the prevalence of P. falciparum-infected mosquitoes (Hughes et al., 2011; Bian et al., 2013; Shaw et al., 2016; Gomes et al., 2017). Although the mechanisms that cause mosquito resistance to Plasmodium remain to be elucidated, experimental Wolbachia infections induce expression of a series of immune effectors and ROS which could potentiate parasite killing (Kambris et al., 2009; Bian et al., 2013).

In addition to inducing the immunity-mediated Plasmodium killing, some bacteria show direct plasmodicidal activity. Enterobacter isolates from Zambian Anopheles kill P. falciparum in the midgut when administrated with the infectious blood meal (Cirimotich et al., 2011). This has been attributed to direct inhibition of ookinete development by the bacteria-produced ROS (Cirimotich et al., 2011). Soluble factors released by Serratia marcescens also inhibit P. falciparum ookinete development in the mosquito (Bahia et al., 2014). Inhibition of P. berghei ookinetes in vivo was linked to the length of the flagella and the motility of S. marcescens (Bando et al., 2013). Currently, it is unclear whether this inhibition is direct or immunity-mediated. Furthermore, oral administration of Chromobacterium sp. isolated from A. aegypti in Panama, induces high mortality in mosquito larva and adults, whereas the surviving mosquitoes exhibit low Plasmodium infection loads (Ramirez et al., 2014). Biochemical analyses identified romidepsin, the histone deacetylase inhibitor, as the plasmodicidal factor, uncovering an essential role of histone modifications in the mosquito stages of Plasmodium. Surprisingly, administration of romidepsin did not affect mosquito survival, suggesting that another bacterial factor mediates the Chromobacterium-induced mortality (Saraiva et al., 2018).

How plasmodicidal properties of mosquito microbiota correlate with dynamics of Plasmodium transmission in the field remains unknown. In laboratory conditions, Serratia sp. and Enterobacteriaceae curb Plasmodium infection (Bando et al., 2013; Tchioffo et al., 2013; Bahia et al., 2014). In contrast, two semi-field studies in Cameroon associated the same bacteria with higher P. falciparum loads (Boissière et al., 2012; Tchioffo et al., 2016). Most of the experimental studies examined the role of microbes in Plasmodium infections using microbiota-free mosquitoes, and the results of the few field studies stress the importance of studying the tripartite interactions between mosquitoes, microbes and parasites in natural conditions.

Treatment of giardiasis primarily relies on the administration of antibiotics like metronidazole. However, due to rising levels of resistance, frequent reports of side effects and clinical failures, there is a growing need for the development of novel alternative treatment strategies (Table 1; Ansell et al., 2015). In the past, it has been shown that the use of Lactobacilli as probiotics in the treatment of giardiasis holds promise. In G. duodenalis-infected gerbils, administration of L. johnsonii La1 leads to reduced infection rates, lack of pathological damage to the epithelial cell layer and absence of immune cell infiltration and inflammation in mice receiving the probiotic compared to the placebo group (Humen et al., 2005). One proposed mechanism of the observed anti-giardial activities of L. johnsonii La1 has been attributed to the metabolic generation of unconjugated bile salts (Pérez et al., 2001; Travers et al., 2016). Very recently, Allain et al. tested in vitro and in vivo the anti-giardial activity of three bile salt hydrolases (BSH), enzymes naturally produced by L. johnsonii La1 (Allain et al., 2018). In vitro treatment of G. duodenalis with increasing concentrations of recombinant BSH47 and BSH56 enzymes revealed a dose-dependent giardicidal activity of both enzymes in the presence of bile. Importantly, the group further demonstrated the anti-giardial activity of rBSH47 after administration to G. duodenalis-infected suckling mice, supporting the view of L. johnsonii La1 as a probiotic candidate for the treatment of Giardia infections.

Along the same line, Enterococcus faecalis SF68, a lactic acid bacterium indigenous to the mammalian commensal microbiota, has also been suggested as a potential probiotic treatment for Giardia. Oral administration of this strain prior to G. lamblia infection led to elevated levels of total IgA levels in small intestine during the acute stage of infection, as well as higher levels of specific anti-Giardia IgA and systemic IgG compared to control animals. Nevertheless, parasitological data were less conclusive and the use of E. faecalis SF68 as a probiotic supporting anti-Giardia immunity merits further investigations (Benyacoub et al., 2005). Overall, it appears that administration of probiotic Lactobacilli in Giardia-infected mice reduces epithelial damage, attenuates overt inflammation and fosters enzymatic giardicidal activity.

Treatment of toxoplasmosis, on the other hand, relies primarily on the administration of pyrimethamine and sulfonamide drugs (Alday and Doggett, 2017). Recently, the administration of Bifidobacterium animalis subsp. lactis to mice chronically infected with T. gondii demonstrated enhanced serum levels of anti-T. gondii IgG and higher numbers of CD19⁺ B-lymphocytes, a reduction in brain cysts, and attenuated intestinal villi inflammation in the probiotic-treated group (Ribeiro et al., 2016). Conversely, previous work in gnotobiotic mice colonized by probiotic E. coli strains revealed that these microbes contribute significantly to intestinal inflammation during T. gondii-infection (Bereswill et al., 2013). These results indicate that the use of probiotic bacterial strains in the treatment of intestinal parasite infections is highly contextual and reports on the potential benefits and risks for host health should be considered in the future design of novel probiotics.

In intestinal helminth infections, few in vivo or in vitro studies have demonstrated mechanisms of action of probiotic bacteria favoring either infection resistance or susceptibility. Treatment of T. muris-infected mice with viable or dead probiotic Lactobacillus casei led to the maintainance of high worm burdens in the chronic phase of infection and concurrently suppressed cellular and Th1/Th2 cytokine responses in secondary lymphoid organs (Dea-Ayuela et al., 2008). On the other hand, administration of live Lactobacillus rhamnosus JB-1 to T. muris-infected mice resulted in accelerated worm expulsion and elevated gut tissue concentrations of IL-10, but not Th2 or Th1 cytokines. Administration of L. rhamnosus enhanced worm expulsion in mice deficient in mucin 2 (Muc2^−/−), a key component of the intestinal mucus layer led to elevated goblet cell frequencies compared to medium-treated Muc2^−/− mice, suggestive of probiotic-dependent induction of additional mucins involved in worm expulsion (McClemens et al., 2013).

The administration of probiotic bacteria against gastrointestinal protozoan parasite infections has gained attention as a novel and effective treatment strategy (Table 1). Numerous studies have highlighted a range of beneficial aspects of probiotic bacteria including support for intestinal antibody responses, reduction in immunopathology and elevated anti-inflammatory cytokine responses, as well as potential competition for nutrients with the invading intestinal parasite species. On the other hand, the introduction of certain probiotic bacteria during intestinal parasite infections could also have a number of detrimental effects, including increasing the numbers of intestinal Tregs and thus potentially facilitating nematode survival or providing support for damaging inflammatory reactions during infection.

The environmental bias of the mosquito microbiome poses a significant challenge for its manipulation for vector control purposes. However, several approaches have been explored for introducing into natural mosquito populations bacteria with anti-Plasmodium properties (Table 1). Wolbachia has been successfully exploited in A. aegypti mosquitoes to interrupt the transmission of dengue virus (Hoffmann et al., 2011, 2014). Efficient Wolbachia application for malaria control requires rapid bacterial spread in the mosquito populations. This spread relies on Wolbachia ability to induce cytoplasmic incompatibility (CI) in the host, which is manifested by the sterility of individuals with different Wolbachia infection status (Bordenstein and Werren, 2007). CI has not been observed in Wolbachia naturally occurring in A. gambiae. Instead, the bacteria appear to induce a modest acceleration of egg-laying rates (Shaw et al., 2016). For experimentally-introduced Wolbachia, successful maternal transmission and CI has been reported in A. stephensi (Bian et al., 2013). Another study has shown inhibition of vertical Wolbachia transmission in A. gambiae and A. stephensi by resident microbiota (Hughes et al., 2014), while other attempts to stably introduce Wolbachia in A. gambiae have been unsuccessful (Kambris et al., 2009; Hughes et al., 2011).

Recently, mosquito colonization with genetically engineered Serratia has been proposed as an alternative transmission-blocking strategy (Wang et al., 2017). In addition to the plasmodicidal activity of S. marcescence described above, the engineered Serratia strains express one or multiple anti-malarial effector proteins and successfully decrease P. falciparum infections in A. stephensi (Wang et al., 2017). Serratia naturally colonizes the mosquito midgut, ovaries and male accessory glands, and is expected to spread throughout mosquito populations. However, the persistence of genetically engineered Serratia under laboratory conditions was only demonstrated for three successive generations with a substantial drop in bacterial loads already in the second generation (Wang et al., 2017).

A surprising link between immune activation and changes in microbiota composition of the mosquito reproductive organs has been reported recently. Transgenic mosquitoes that expressed an active form of the REL2 transcriptional factor in the midgut after a blood meal were reported to inhibit bacterial proliferation and Plasmodium invasion (Dong et al., 2011). Unexpectedly, activation of the IMD pathway modified the mosquito mating behavior leading to the preferential mating of transgenic males with wild-type females (Pike et al., 2017). Although the exact mechanism is unclear, the authors proposed that transgene expression inhibits bacterial proliferation in the male reproductive organs and facilitates the spread of the transgene (Pike et al., 2017). Surprisingly, female mating preference was not affected by the transgene expression. Whether such behavioral manipulation was caused by a particular bacterial species or the overall bacterial loads and whether transgenesis-induced changes were male-specific remains to be investigated.

Another interesting approach to mosquito control exploits the entomopathogenic bacteria Chromobacterium sp. and the fungus Beauveria bassiana that exhibit plasmodicidal activities. As discussed above, Chromobacterium interferes with Plasmodium through histone modification processes and induces mortality by an as yet unknown mechanism (Saraiva et al., 2018). B. bassiana, on the other hand, downregulates IMD-mediated immunity and expression of dual oxidase DUOX, causing midgut dysbiosis and systemic infections by opportunistic bacteria that kill mosquitoes (Wei et al., 2017). Therefore, disrupting or manipulating the mosquito microbiome often has fatal consequences for the vector that may directly or indirectly contribute to the inhibition of Plasmodium development.

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.